Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

University of California Irvine (UCI) logo

University of California Irvine (UCI)




Lung Cancer


Behavioral: Patient education
Behavioral: Provider Reminders
Other: Usual Care
Behavioral: Referral to financial navigation resources
Behavioral: Patient Reminders
Behavioral: Brief Patient Education

Study type


Funder types



UCI 23-219 (Other Identifier)

Details and patient eligibility


The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.


60 estimated patients




50 to 80 years old


Accepts Healthy Volunteers

Inclusion criteria

  • Aged 50- 80 years of age.
  • Be able to speak English and Spanish
  • Must have a scheduled appointment with their Primary Care Providers within next one to three months.
  • The Scheduled PCP appointment is at any of the 4 University of California Irvine Health (UCI Health) primary care clinics in Orange County including two UCI federally qualified health centers
  • History of 20-pack year smoking history ( based on survey self-report)
  • Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self-report)

Exclusion criteria

  • Prior history of lung cancer
  • Chest CT for any reason in the last 12 months based on self-report and UCI EMR
  • History of Alzheimer's disease or dementia

Trial design

Primary purpose




Interventional model

Parallel Assignment


Single Blind

60 participants in 2 patient groups

Arm A: Enhanced Usual Care
Experimental group
Usual Care + Brief Educational Material
Behavioral: Brief Patient Education
Other: Usual Care
Arm B: Empower Latinx
Experimental group
PCP notifications of patients' LCS eligibility (addressing provider time constraints and barrier in identifying eligible patients); Patients' education (addressing knowledge barriers); Patients' referral to financial navigation resources (addressing health-related social risks) Patients' reminder to discuss LCS during PCP visit.
Behavioral: Patient Reminders
Behavioral: Referral to financial navigation resources
Other: Usual Care
Behavioral: Provider Reminders
Behavioral: Patient education

Trial contacts and locations



Central trial contact

Richard Echeverria; Gelareh Sadigh, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems